MONDAY, July 1, 2024 (HealthDay Information) — Present screening requirements may miss early-stage prostate most cancers in transgender girls, a brand new examine warns.
Prostate most cancers exams search for prostate-specific antigen (PSA), a protein produced by the small gland. Blood ranges of PSA are usually elevated in folks with prostate most cancers.
However the estrogen that many transgender girls take as a part of their gender-affirming care “drastically lowers PSA ranges, which may imply the brink we’re utilizing as ‘regular’ is just too excessive to detect early-stage most cancers in these sufferers,” mentioned senior researcher Dr. Stephen Freedland, chair of prostate most cancers at Cedars-Sinai Medical Heart in Los Angeles.
Present pointers maintain that PSA ranges above 4 nanograms per milliliter of blood recommend most cancers may very well be current. At these ranges, a prostate biopsy may be ordered to examine for most cancers.
For this examine, revealed June 26 within the Journal of the American Medical Affiliation, researchers analyzed the Veterans Well being Administration medical information of 210 transgender girls with out prostate most cancers who had been taking estrogen.
“We discovered that the median PSA worth, the midpoint within the vary of individuals, was 0.02 ng/mL, which is fiftyfold decrease than PSA values reported in similar-aged cisgender males,” mentioned lead researcher Dr. Farnoosh Nik-Ahd, a urology resident on the College of California, San Francisco.
This implies transgender girls taking estrogen who develop prostate most cancers aren’t more likely to see their PSA enhance sufficient to set off a biopsy — no less than, not till the most cancers is at a later stage, Nik-Ahd defined.
At that time, the prostate most cancers might be extra life-threatening and troublesome to deal with.
Further analysis is required to pinpoint particular PSA ranges that point out a transgender lady on estrogen is at larger danger for growing prostate most cancers, Freedland mentioned.
Freedland famous that the examine shouldn’t be a name for all transgender girls to be screened, nevertheless.
“We all know that PSA screening reduces the danger that cisgender males ages 55 to 69 will die of prostate most cancers, however we don’t know that it does the identical factor for transgender girls taking estrogen,” Freedland mentioned in a Cedars SInai information launch. “Nevertheless, as a result of a few of these girls are being screened, we need to increase consciousness that their typical PSA ranges are completely different.”
Within the meantime, Freedland advises transgender girls taking estrogen to seek the advice of with their medical doctors.
“Remember that you’ve a prostate and that prostates can grow to be cancerous,” Freedland mentioned. “The easiest way we all know to seek out these cancers early and scale back the danger of demise is a PSA take a look at. And when you select to try this, remember the fact that the take a look at values usually are not calibrated for you.”
“Convey your outcomes — and probably this examine — to your urologist in order that your outcomes might be interpreted by somebody who understands what to do with that data,” Freedland mentioned.
Extra data
The Cleveland Clinic has extra about transgender girls and prostate most cancers.
SOURCE: Cedars-Sinai Medical Heart, information launch, June 26, 2024
